The Ritonavir-Lopinavir Tablets, cataloged under National Stock Number 6505-01-539-1079, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Abbvie Inc. The record lists 6 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-539-1079 |
| Primary Part Number | NDC00074-4014-12 |
| Item Name | Ritonavir-Lopinavir Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Abbvie Inc |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| 05904723 | Kohlpharma Gmbh (DEU) |
| 11006342 | Abacus Medicine Berlin Gmbh (DEU) |
| 00692587 | Abbvie Deutschland Gmbh & Co. Kg (DEU) |
| KALETRA 200MG/50MG - 120 COMP. | Abbott Sa (BEL) |
| 11524315 | Abacus Medicine Berlin Gmbh (DEU) |
| NDC00074-4014-12 PRIMARY | Abbvie Inc (USA) |
| Reference | Meaning |
|---|---|
| 06-0254 | 5/1 Secondary reference U.S. Government activity |
| KALETRA | 5/1 Secondary reference Abbvie Us Llc |
| 2270361 | 6/9 Informative reference only Association Pharmaceutique Belge-Algemene Pharmaceutische Bond |
NSN 6505-01-539-1079 is a Ritonavir-Lopinavir Tablets, manufactured by Abbvie Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-539-1079 has 6 manufacturer part numbers on file: 05904723 (Kohlpharma Gmbh), 11006342 (Abacus Medicine Berlin Gmbh), 00692587 (Abbvie Deutschland Gmbh & Co. Kg), KALETRA 200MG/50MG - 120 COMP. (Abbott Sa), 11524315 (Abacus Medicine Berlin Gmbh) and 1 more.
Key specifications for NDC00074-4014-12: Special Features: 50MG RITONAVIR, 200MG LOPINAVIR; FILM COATED TABLETS; 120 TABS PER BT; STORE AT 20-25DEG C DEGC; Part Name Assigned by Controlling Agency: RITONAVIR-LOPINAVIR KALETRA 50MG-200MG TABS 120S. 0 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.